The laser technology will treat patients with Benign Prostatic Hyperplasia (BPH)and allows freedom from the obstructive urinary symptoms that accompany BPH and has been proven safe and effective in clinical studies, AMS said.

The acquisitions follow the successful introduction of the GreenLight laser into a Victorian public hospital in 2008 and were made possible through funding initiatives from the Commonwealth of Australia, the Victorian Department of Health and Queensland Health.

According to AMS, GreenLight combines the effectiveness of the traditional invasive surgical procedure, Transurethral Resection of the Prostate (TURP), with fewer side effects, offering shorter hospital stays and a return to normal, non-strenuous activities within days.

AMS Asia Pacific, Latin America and Canada vice president and general manager Mike Ryan said that these acquisitions demonstrate the confidence that the Australian public health systems have for advanced BPH treatment technology like the GreenLight laser.

“An increasing number of men in Australia will gain access to this cutting-edge technology to treat their prostate health issues, resulting in a better all-around quality of life,” Ryan said.